EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 724.43K |
Day Range | - - - |
52 Wk Range | 5.67 - 30.99 |
Market Cap | $476.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 19.96% |
Days to Cover | 20.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) through any online brokerage.
Other companies in EyePoint Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
EyePoint Pharmaceuticals has a consensus price target of $32.78.
The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $8.91 last updated September 20, 2024 at 4:03 PM EDT.
There are no upcoming dividends for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.